ICD10 code of Pars Planitis and ICD9 code

Pars planitis is a specific form of intermediate uveitis classified under ICD-10 code H30.2 (Posterior cyclitis), while it was previously categorized under ICD-9 code 363.21. These diagnostic codes are essential for clinicians to document this chronic inflammatory condition, which affects the peripheral retina and the pars plana region of the eye.

What is the clinical classification of Pars Planitis?

Pars planitis is a subtype of intermediate uveitis characterized by inflammation primarily affecting the vitreous, peripheral retina, and ciliary body. Because it is a specific clinical entity, medical billing often utilizes the broader ICD-10 code H30.2 to capture the inflammatory nature of Pars planitis. Identifying the correct code is vital for patients seeking insurance coverage for specialized treatments, including immunosuppressive therapies or local corticosteroid injections.

How is Pars Planitis diagnosed?

Diagnosis of Pars planitis is primarily clinical, based on a comprehensive dilated eye exam. Ophthalmologists look for "snowbanking" (exudates over the pars plana) and "snowballs" (inflammatory debris in the vitreous). Key diagnostic features include:

• Presence of cells and flare in the vitreous humor.


• Peripheral retinal vascular sheathing.


• Absence of primary infection or systemic autoimmune disease.


• Visual acuity changes often associated with cystoid macular edema.

Is there a support network for those with Pars Planitis?

Living with a vision-threatening condition like Pars planitis can be isolating, but you are not alone. Currently, 21 people within the DiseaseMaps.org community have shared their personal journeys with Pars planitis. Connecting with others who understand the burden of chronic eye inflammation and the side effects of long-term steroid use can provide significant emotional relief and practical advice for navigating clinical care.

Next steps

• Consult a retina specialist or uveitis sub-specialist to confirm your diagnosis and treatment plan.


• Maintain a detailed log of your symptoms and vision changes to discuss during follow-up appointments.


• Join the Pars planitis community at DiseaseMaps.org to connect with others sharing similar experiences.


• Inquire with your ophthalmologist about the latest clinical trials regarding biologic therapies for refractory uveitis.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• National Eye Institute (NEI) - Uveitis Information.


• Orphanet: Database of rare diseases and orphan drugs.


• International Uveitis Study Group (IUSG) criteria for intermediate uveitis.


• American Academy of Ophthalmology (AAO) clinical guidelines on uveitis.